Up to 140 job cuts at Sanofi GermanySanofi is planning around 140 job cuts in corporate functions in Germany by 2020, reported FAZ on Wednesday (p22) (APMHE 61023).
Boehringer plans job cuts in FranceGerman pharmaceutical company Boehringer Ingelheim plans to cut more than 300 jobs in France, reported FAZ on Tuesday (p8) (APMHE 61003).
Bayer employee representative complains about media reportsBayer employee representative and central works council chairman Oliver Zuehlke has complained about media reports on the company's cost-cutting plan, weekly Die Zeit wrote on Thursday.
Bayer denies rumours about contact with hedge fund ElliottBayer chief executive Werner Baumann has denied having had any contact with U.S.-based hedge fund Elliott Management, reported FAZ on Tuesday (p19) and Sueddeutsche Zeitung (SZ) on Wednesday (p17).
Bayer attempts transparency on glyphosate studiesBayer has published online a 'transparency platform' of studies on weedkiller glyphosate in an attempt to be more transparent, SZ wrote on Saturday (p28).
Fresenius expects Kabi division to grow in 2019Medical group Fresenius issued a profit warning for 2019 and 2020 (APMHE 60973) but is still expecting its drug division Kabi's operative result to grow at a low to medium single-digit percentage in 2019, Die Welt reported on Saturday (p10) (APMHE 60973).
German Health Minister proposes compromise on mail order pharmaciesGerman Health Minister Jens Spahn has proposed a compromise to pharmacists in the dispute over mail order pharmacies, FAZ (p19), Handelsblatt (p10 and 12) and SZ (p4 and 6) reported on Wednesday and Wirtschaftswoche on Friday (p12)
German monopolies commission suggests discounts in pharmaciesGermany's monopolies commission has recommended the introduction of discounts on copayments by patients in order to enhance competition among mail order and brick-and-mortar pharmacies, Die Welt (p9) and FAZ (p19) reported on Monday.
Paediatric drug studies questionedExperts are calling into question the benefit of conducting drug studies on children, FAZ reported on Wednesday (p33).
Start-up founder invests in medical cannabisGerman start-up founder Sebastian Diemer has invested in newly founded Farmako, a research-based pharmaceutical company that aims to develop new cannabis products such as capsules, oils or inhalers, Handelsblatt wrote on Tuesday (p46).
Bavarian doctors opposed to doctors' information systemThe regional doctors' association (KV) of Bavaria is not in favour of the information system on drug assessment by health technology assessment (HTA) body G-BA being included in their practice software, SZ reported on Wednesday (p48).
Roche loses pharma headRoche has lost its head of pharma Daniel O'Day, who has resigned to head up California-based pharmaceutical and biotech company Gilead Sciences at the beginning of March, FAZ (p20) and Handelsblatt (p46) reported on Tuesday (APMHE 60980).
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.